lymphocyte activation

Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to lymphocyte activation: macrophage activation


any of the mononuclear nonphagocytic leukocytes found in the blood, lymph, and lymphoid tissues; they comprise the body's immunologically competent cells and their precursors. They are divided on the basis of ontogeny and function into two classes, B and T lymphocytes, responsible for humoral and cellular immunity, respectively. Most are small lymphocytes 7–10 μm in diameter with a round or slightly indented heterochromatic nucleus that almost fills the entire cell and a thin rim of basophilic cytoplasm that contains few granules. When activated by contact with antigen, small lymphocytes begin macromolecular synthesis, the cytoplasm enlarges until the cells are 10–30 μm in diameter, and the nucleus becomes less completely heterochromatic; they are then referred to as large lymphocytes or lymphoblasts. These cells then proliferate and differentiate into B and T memory cells and into the various effector cell types, B cells into plasma cells and T cells into helper, cytotoxic, and suppressor cells. See subentries here and under cell. adj., adj lymphocyt´ic.
Origin of B- and T-lymphocytes responsible for cellular and humoral immunity. In response to antigens, B- and T-lymphocytes are sensitized by lymphoid tissue.
lymphocyte activation stimulation of lymphocytes by specific antigen or nonspecific mitogens resulting in synthesis of RNA, protein, and DNA and production of lymphokines; it is followed by proliferation and differentiation of various effector and memory cells. Activation is accompanied by morphologic changes known as lymphocyte transformation, in which small, resting lymphocytes are transformed into large, active lymphocytes (lymphoblasts); the formation of lymphoblasts is referred to as blastogenesis.
amplifier T l's a T lymphocyte of the CD8 cell type that modifies a developing immune response by releasing nonspecific signals to which other T lymphocytes (either effector or suppressor cells) respond.
B l's “bursa-equivalent” lymphocytes; a type that develop from stem cells in hematopoietic tissue, including the blood islands of the fetal yolk sac, the fetal liver and spleen, and the bone marrow. The B in the name refers to the bursa of fabricius, an organ in birds where B cell differentiation occurs; however, no analogous organ has been found in mammals. Called also B cells.

B lymphocytes are involved in humoral immunity, the secretion of antibodies. A mature B lymphocyte can be activated by the binding of an antigen to cell surface receptors. This induces proliferation of the cell, resulting in a clone of cells specific for that antigen. These cells can then differentiate and begin to secrete immunoglobulin (Ig) molecules; this step involves interaction with helper T lymphocytes. All the cells of a clone secrete Ig with identical antigen binding sites. Antibody-secreting cells can have the morphology of plasma cells, large lymphocytes, or lymphoblasts.
CD4 T l's (CD4+ T l's) CD4 cells.
CD8 T l's (CD8+ T l's) CD8 cells.
cytotoxic T l's differentiated T lymphocytes, marked by CD4 and CD8 antigens, able to recognize and lyse target cells bearing specific antigens recognized by their antigen receptors. The cytotoxic activity requires firm binding of the lymphocyte to the target cell to produce holes in its plasma membrane with loss of its cellular contents and osmotic lysis. These lymphocytes are important in graft rejection and killing of tumor cells and virus-infected host cells. Called also killer or killer T cells.
lymphocyte proliferation test a functional test of the ability of lymphocytes to respond to mitogens, specific antigens, or allogenic cells. The test with allogenic cells, called a mixed lymphocyte culture (MLC), is commonly performed for transplantation tissue typing; all three types of stimulants are used in investigation of immunodeficiency. Commonly used mitogens are phytohemagglutinin (PHA), concanavalin A (ConA), and pokeweed mitogen (PWM); commonly used antigens are PPD (tuberculin), Candida antigen, and streptokinase-streptodornase.
Rieder's lymphocyte a myeloblast with a nucleus and several wide, deep indentations suggesting lobulation, seen in Rieder's cell leukemia and sometimes chronic lymphocytic leukemia. Called also Rieder's cell.
T l's “thymus-dependent” lymphocytes; a type that originates from a stem cell in hematopoietic tissue and undergoes differentiation in the thymus when triggered by thymopoietin. Called also T cells.  When activated by antigens such as the CD4 antigen or the CD8 antigen, T lymphocytes differentiate into the various types of regulatory and effector T cells (see CD4 cells and CD8 cells).

The CD8 cells called cytotoxic T cells or killer T cells are responsible for cell-mediated cytotoxicity, which is the killing of cells bearing specific antigens, the mechanism involved in cell-mediated immunity, delayed hypersensitivity, and killing of tumor cells and transplant tissue cells. A subpopulation, the LAK cells, is involved in the production of lymphokines, substances released into the blood that cause activation or inhibition of macrophages, destroy target cells, or are chemotactic for the various types of leukocytes. The CD4 cells called helper T cells help B lymphocytes recognize certain antigens. Amplifier T lymphocytes are CD8 cells that enhance the activity of cytotoxic T cells. Suppressor T cells are CD8 cells that suppress antibody synthesis by their action on helper cells and B lymphocytes.

lymphocyte activation

The use of an antigen (or mitogen in vitro) to stimulate lymphocyte metabolic activity.
References in periodicals archive ?
The CVD915 strain was evaluated in a breast cancer murine model, and it delayed tumor growth in association with [CD8.sup.+] and B220+ lymphocyte activation, but not [CD4.sup.+] cells.
Since, at different points of lymphocyte activation process, different activation markers are upregulated, it is entirely possible that the differences in the time passed between the onset of PE and the sample collection could account for the abovementioned incongruity, especially since we also observed an elevating tendency in the expression of CD25 in CD4+ lymphocytes, which did not reach a significant level.
Effect of siRNA mediated suppression of signaling lymphocyte activation molecule on replication of peste des petits ruminants virus in vitro.
Therefore, if any participants had coccidioidomycosis that did not resolve because of a [T.sub.H]2 immune response, we may not have been able to detect the infection because of inadequate lymphocyte activation (i.e., a false-negative test result) (9).
The most simple method uses a negative isotype control, thereby defining all cells with positive CD38 expression, and has been used to define healthy control ranges [62], for pathological classification of chronic lymphocytic leukaemia [63,64], and also by some authors describing the pathology of lymphocyte activation in HIV-1 infection [7,8, 13-15, 65,66] and other viral infections such as EBV [67,68].
In our study, RANTES levels were observed to be higher in control groups than the specimens stimulated by MRSA and MSSA after 24 h; the reason why the levels increased in the specimens stimulated by MRSA and MSSA after 48 h may probably be explained by the fact that the increase was more clear after 48 h depending on lymphocyte activation after the stimulation by microorganisms and the late expression of RANTES following the transient increase in RANTES in the first 24 h.
It is well known that there is cytoskeletal remodeling in lymphocyte activation (Miletic et al., 2003).
A particular advantage of the present invention is that it provides lymphocyte activation of receptor found on all B cells, but only on a subset of T cells.
The study's lead researchers selected anti-inflammatory and lymphocyte activation assays because of EpiCor's high oxygen radical absorbance capacity (ORAC) value, as well as the initial evidence pointing to EpiCor's favorable immunomodulating effects on factory employees manufacturing the ingredient.
This leads us to consider 1) the therapeutic use of drugs that diminish lymphocyte activation (cyclosporine being the prototype), 2) treating HIV as early as possible, and 3) finding the mechanisms involved in impairing uninfected T cells and attempting to do something about it.